IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, van Deventer SJ, van der Poll T.
Verbon A, et al. Among authors: van deventer sj, van der poll t.
J Immunol. 2001 Mar 1;166(5):3599-605. doi: 10.4049/jimmunol.166.5.3599.
J Immunol. 2001.
PMID: 11207321
Clinical Trial.